Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Canada
Deutschland
España
France
Italia
Schweiz (DE)
Suisse (FR)
United Kingdom
United States
Settings
Dynamic quotes
OFF
ON
Markets
Equities
North America
Europe
Asia
Oceania
Middle East
»
More Equities
Indexes
DOW JONES
S&P 500
NASDAQ 100
TSX COMP
NIKKEI 225
»
More Indexes
Currency / Forex
EUR / USD
GBP / USD
USD / JPY
USD / CAD
AUD / USD
»
More Currencies
Commodities
GOLD
Crude Oil (WTI)
Crude Oil (BRENT)
SILVER
PLATINUM
»
More Commodities
Trackers & ETF
Rankings and News
Advanced Search
Cryptocurrencies
BITCOIN
ETHEREUM
News
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Business Leaders
Cryptocurrencies
Cybersecurity
Economic calendar
Listed companies
Analyst reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit warnings
Appointments
Press Releases
Events
Corporate actions
Financial calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Telecommunications Services
Utilities
Analysis
All Analysis
Must Read
Daily briefing
Weekly market update
Stock Trading Strategies
Stock Picks
All stock picks
Subscribe
Portfolios
My Portfolio
Virtual portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment style
Yield stocks
Growth stocks
Undervalued Stocks
Investment themes
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Let’s all cycle!
Fintechs
Ageing Population
Top / Flop
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
Screeners
Investment selections
Water
Sin stocks
Biotechnology
At the foot of the Mont Blanc
Place your bets
Europe's family businesses
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic chart
Financial calendar
Economic calendar
Sector research
Currency converter
ProRealTime Trading
Our Services
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
MarketScreener Homepage
>
Equities
>
Nasdaq
>
VYNE Therapeutics Inc.
VYNE
VYNE THERAPEUTICS INC.
(VYNE)
Add to my list
Report
Real-time Estimate Cboe BZX -
01/27 09:11:42 am
2.295
USD
-8.20%
01/26
Wall Street Wavers Pre-Bell Amid Earnings Deluge
MT
01/26
VYNE THERAPEUTICS
: Announces $50 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
AQ
01/26
VYNE THERAPEUTICS INC.
: Results of Operations and Financial Condition (form 8-K)
AQ
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Other languages
Press Releases
Official Publications
Sector news
Most relevant news about VYNE THERAPEUTICS INC.
01/26
VYNE THERAPEUTICS
: Announces $50 Million Registered Direct Offering of Common S..
AQ
01/22
VYNE THERAPEUTICS
: Announces Contract Execution for AMZEEQ and ZILXI with Major..
AQ
01/21
VYNE THERAPEUTICS
: Signs Deal With Pharmacy Benefit Manager for FDA-Approved Sk..
MT
01/21
VYNE THERAPEUTICS
: Announces Contract Execution for AMZEEQ® (minocycline) and Z..
AQ
01/05
VYNE THERAPEUTICS
: to Present at the LifeSci Partners 10th Annual Healthcare Co..
AQ
2020
VYNE THERAPEUTICS
: Completes End-of-Phase 2 Meeting With FDA for FCD105 to Trea..
MT
2020
VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for ..
GL
2020
VYNE THERAPEUTICS
: to Join Nasdaq Biotechnology Index
MT
2020
VYNE THERAPEUTICS
: Added to Nasdaq Biotechnology Index
AQ
2020
VYNE THERAPEUTICS
: Wins US Patent for Acne Treatment Amzeeq
MT
2020
VYNE THERAPEUTICS
: Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (mino..
AQ
2020
VYNE Therapeutics Announces Publication of Long-term Safety & Efficacy Data f..
GL
2020
VYNE THERAPEUTICS
: to Present at the 32nd Annual Piper Sandler Healthcare Confe..
AQ
2020
VYNE Therapeutics to Present at the 32nd Annual Piper Sandler Healthcare Conf..
GL
2020
Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q3 EPS $-0.13, vs. Street Est o..
MT
More most relevant news
All news about VYNE THERAPEUTICS INC.
01/26
Wall Street Wavers Pre-Bell Amid Earnings Deluge
MT
01/26
VYNE THERAPEUTICS
: Announces $50 Million Registered Direct Offering of Common S..
AQ
01/26
VYNE THERAPEUTICS INC.
: Results of Operations and Financial Condition (form 8-K..
AQ
01/22
VYNE THERAPEUTICS
: Announces Contract Execution for AMZEEQ and ZILXI with Major..
AQ
01/21
VYNE THERAPEUTICS
: Signs Deal With Pharmacy Benefit Manager for FDA-Approved Sk..
MT
01/21
VYNE THERAPEUTICS
: Announces Contract Execution for AMZEEQ® (minocycline) and Z..
AQ
01/07
VYNE THERAPEUTICS INC.
: Regulation FD Disclosure, Financial Statements and Exhi..
AQ
01/05
VYNE THERAPEUTICS
: to Present at the LifeSci Partners 10th Annual Healthcare Co..
AQ
2020
VYNE THERAPEUTICS
: Completes End-of-Phase 2 Meeting With FDA for FCD105 to Trea..
MT
2020
VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for ..
GL
More news
News in other languages on VYNE THERAPEUTICS INC.
- No features available -
More news
Press releases
01/26
VYNE THERAPEUTICS
: Announces $50 Million Registered Direct Offering of Common S..
AQ
01/26
VYNE THERAPEUTICS INC.
: Results of Operations and Financial Condition (form 8-K..
AQ
01/22
VYNE THERAPEUTICS
: Announces Contract Execution for AMZEEQ and ZILXI with Major..
AQ
01/21
VYNE THERAPEUTICS
: Announces Contract Execution for AMZEEQ® (minocycline) and Z..
AQ
01/07
VYNE THERAPEUTICS INC.
: Regulation FD Disclosure, Financial Statements and Exhi..
AQ
More press releases
Powered by Scoopnest.com
Slave